retatrutide news october 2025 Lilly's Scores Triple Trial Triumph With 26% Weight Loss, But New Safety Signal Emerges Eli Lilly's Next-Gen Obesity Drug

Akkermansia muciniphila is a gut bacterium that colonizes the intestinal mucus layer and has been increasingly studied for its relationship to metabolic health and GLP-1 secretion

Liposomal delivery wraps it in phospholipid layers, the same material your cell membranes are made of, which protects it through the stomach and allows it to pass into the bloodstream more intact

They are prescribed off-label by clinicians based on clinical judgment, existing research, and patient-specific factors

But the decrease in appetite can sometimes lead to under-fueling , especially if youre active

Consult a healthcare provider or the team at Classy Aesthetics Wellness to determine the best treatment plan